DS0705 -

Improved pharmacovigilance and signal detection with groupings – PEGASE

Submission summary

Providing new technologies to access data implies to reconcile, on one hand, the expressivity of formal query languages and, on the other hand, the usability of these tools for the end user. For example, SQL is admitted as a query language in the majority of relational databases, but it suffers from an insufficient level of conviviality for an end user who is not familiar with databases. Therefore, interfaces are developed to improve the usability of data-access methods and to conceal the difficulties related to technical languages. Unfortunately, end user interfaces often limit the access to the full expressivity of these languages.
Recently, rapid growth of the semantic Web and of linked open data introduced a new paradigm for data accessibility, which allows requesting data in a more efficient way. But using formal languages such as SPARQL is difficult for non-specialist staff, and requires understanding the RDF resource, which is an additional difficulty for the user. In order to improve the access to semantic resources, interfaces were proposed, but the proof that such interfaces improve user experience still needs to be established.
Pharmacovigilance is the activity related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The Adverse Drug Reactions (ADRs) are coded in pharmacovigilance databases using the MedDRA (Medical Dictionary for Regulatory Activities) terminology. In France, in the public sector, health professionals and patients can spontaneously report ADRs to regional pharmacovigilance centers (CRPV) which register these cases in the French pharmacovigilance database.
Some partners of the project have already developed a semantic resource, OntoADR which allows querying MedDRA using formal languages, but this query method was unattainable for pharmacoviglants. The hypothesis of the PEGASE project (Pharmacovigilance Enrichie par des Groupements Améliorant la détection des Signaux Émergents) is that interfaces with better usability level will allow to enhance user experience whilst preserving the high expressivity of formal queries.
To query OntoADR, several types of interfaces will be evaluated. We will consider interfaces based on forms, on graphs, or on natural language. In addition, interfaces based on the VMC (Visualization of medical concepts) iconic language, and visualization with rainbow boxes will be developed and evaluated. A particularity of the project is to propose, throughout the development of prototypes, a user-centered approach. The design of this approach will take into account the cognitive process of the pharmacovigilance activity. The prototypes will be developed by following the principles of agile software development, including several cycles of ergonomic evaluation, allowing the improvement of the usability of the prototypes. A final evaluation of the usability will involve pharmacovigilance experts.
The project is coordinated by the Unit of Public Health and Medical Informatics of the CHU University Hospital of Saint Etienne and envolves another laboratory of medical informatics, INSERM U1142 LIMICS. The LIS team of IRISA will adapt its tool SPAKLIS for the purposes of the project. CIC-IT Evalab, an ergonomics laboratory, will lead the usability studies of developed prototypes in connection with end users. These end users are the pharmacovigilants of CRPV (Besançon, Lille, Paris HEGP and Toulouse), who will be also responsible of the evaluation on their activities, especially for querying case reports in the French pharmacovigilance database and for statistical signal detection.

Project coordination

Cedric Bousquet (Service de santé publique et de l'information médicale)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

IRISA Institut de Recherche en Informatique et Systèmes Aléatoires
CRPV_T CRPV de Toulouse
CRPV_P CRPV Paris HEGP
CRPV_L CRPV Nord-Pas-de-Calais
CRPV_B CRPV de Franche-Comté
CIC-IT Centre Investigation Clinique - Innovations Technologiques
INSERM DR Paris6 U1142 Institut National de la santé et de la Recherche Médicale DR6
SSPIM Service de santé publique et de l'information médicale

Help of the ANR 587,720 euros
Beginning and duration of the scientific project: September 2016 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter